Latest News

  • Alkermes to Take Part in SVB Leerink 10th Annual Global Healthcare Conference Read More
  • Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2020 and Provides Financial Expectations for 2021 Read More
  • Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results Read More
  • NIDA-Funded Study Evaluating Extended-Release Injectable Naltrexone Plus Bupropion for the Treatment of Methamphetamine Use Disorder Published in New England Journal of Medicine Read More

Investors